Literature DB >> 15792808

Multiple-mutation at a potential ligand-binding region decreased allergenicity of a mite allergen Der f 2 without disrupting global structure.

Takuya Nakazawa1, Toshiro Takai, Hideki Hatanaka, Eri Mizuuchi, Teruyuki Nagamune, Ko Okumura, Hideoki Ogawa.   

Abstract

We assessed the effect of multiple-mutations within one IgE-binding area on allergenicity of Der f 2. The triple-mutant of Der f 2, P34/95/99A, exhibited the most significant reduction of allergenicity and circular dichroism analysis showed that the global structure of Der f 2 was maintained in P34/95/99A. These results indicate that such a strategy is effective when designing allergen-vaccines, which achieve less allergenicity for a broad population of patients without disrupting the global structure. Structurally, Der f 2 is a member of the MD-2 related lipid-recognition proteins. The sites for the triple-mutation located on the characteristically charged entrance of a cavity and corresponded to the regions critical to ligand-binding in the Niemann-Pick type 2 disease protein and MD-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15792808     DOI: 10.1016/j.febslet.2005.01.088

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  A Human IgE Antibody Binding Site on Der p 2 for the Design of a Recombinant Allergen for Immunotherapy.

Authors:  Jill Glesner; A Brenda Kapingidza; Magdalena Godzwon; Lesa R Offermann; Geoffrey A Mueller; Eugene F DeRose; Paul Wright; Crystal M Richardson; Judith A Woodfolk; Lisa D Vailes; Sabina Wünschmann; Robert E London; Martin D Chapman; Mats Ohlin; Maksymilian Chruszcz; Anna Pomés
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

2.  Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.

Authors:  Kuan-Wei Chen; Katharina Blatt; Wayne R Thomas; Ines Swoboda; Peter Valent; Rudolf Valenta; Susanne Vrtala
Journal:  J Allergy Clin Immunol       Date:  2012-07-11       Impact factor: 10.793

3.  Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.

Authors:  K-W Chen; M Focke-Tejkl; K Blatt; M Kneidinger; A Gieras; F Dall'Antonia; I Faé; G Fischer; W Keller; P Valent; R Valenta; S Vrtala
Journal:  Allergy       Date:  2012-02-17       Impact factor: 13.146

4.  Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.

Authors:  Urai Chaisri; Anchalee Tungtrongchitr; Nitaya Indrawattana; Panisara Meechan; Watchara Phurttikul; Natt Tasaniyananda; Nawannaporn Saelim; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.